Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Roche, Genentech and Biogen Idec announce positive results from first phase III trial of ocrelizumab
Roche, Genentech and Biogen Idec announce positive results from first phase III trial of ocrelizumab
Roche, Genentech and Biogen Idec announce positive results from first phase III trial of ocrelizumab
Submitted by
admin
on December 13, 2009 - 12:13pm
Source:
PR-Canada
News Tags:
Roche
Genentech
Biogen Idec
ocrelizumab
Headline:
Roche, Genentech and Biogen Idec announce positive results from first phase III trial of ocrelizumab
Do Not Allow Advertisers to Use My Personal information
